149 related articles for article (PubMed ID: 29038462)
1. Development of an athyroid mouse model using
Oh JM; Lee HW; Kalimuthu S; Gangadaran P; Baek SH; Han MH; Hong CM; Jeong SY; Lee SW; Lee J; Ahn BC
Sci Rep; 2017 Oct; 7(1):13284. PubMed ID: 29038462
[TBL] [Abstract][Full Text] [Related]
2. Single-Photon Emission Computed Tomography for Preclinical Assessment of Thyroid Radioiodide Uptake Following Various Combinations of Preparative Measures.
Zwarthoed C; Chatti K; Guglielmi J; Hichri M; Compin C; Darcourt J; Vassaux G; Benisvy D; Pourcher T; Cambien B
Thyroid; 2016 Nov; 26(11):1614-1622. PubMed ID: 27349131
[TBL] [Abstract][Full Text] [Related]
3. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma.
Long B; Li L; Yao L; Chen S; Yi H; Ye X; Xu D; Wu P
J Cancer Res Ther; 2015 Nov; 11 Suppl():C244-7. PubMed ID: 26612446
[TBL] [Abstract][Full Text] [Related]
4. Low-iodine diet revisited: importance in nuclear medicine imaging and management.
Hinds SR; Stack AL; Stocker DJ
Clin Nucl Med; 2008 Apr; 33(4):247-50. PubMed ID: 18356660
[TBL] [Abstract][Full Text] [Related]
5. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
[TBL] [Abstract][Full Text] [Related]
6. The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
Ozdemir D; Cuhaci FN; Ozdemir E; Aydin C; Ersoy R; Turkolmez S; Cakir B
Nucl Med Commun; 2016 Jun; 37(6):640-5. PubMed ID: 26895488
[TBL] [Abstract][Full Text] [Related]
7. Metastatic insular thyroid carcinoma: visualized on Tc-99m pertechnetate, Tc-99m MDP and iodine-131 scintigraphy; a review of the literature for other radionuclide agents.
Kiratli PO; Kara PP; Ergün EL; Gedikoğlu G
Ann Nucl Med; 2004 Jul; 18(5):443-6. PubMed ID: 15462407
[TBL] [Abstract][Full Text] [Related]
8. Influence of (99m)Tc-pertechnetate thyroid imaging on radioactive iodine uptake.
Guo N; Yang K; Lin YS; Wang T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):267-70. PubMed ID: 24997818
[TBL] [Abstract][Full Text] [Related]
9. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
10. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
[TBL] [Abstract][Full Text] [Related]
11. Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice.
Franken PR; Guglielmi J; Vanhove C; Koulibaly M; Defrise M; Darcourt J; Pourcher T
Thyroid; 2010 May; 20(5):519-26. PubMed ID: 20384490
[TBL] [Abstract][Full Text] [Related]
12. Low iodine diet in differentiated thyroid cancer: a review.
Li JH; He ZH; Bansal V; Hennessey JV
Clin Endocrinol (Oxf); 2016 Jan; 84(1):3-12. PubMed ID: 26118628
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer.
Ito S; Iwano S; Kato K; Naganawa S
Ann Nucl Med; 2018 Jul; 32(6):418-424. PubMed ID: 29766463
[TBL] [Abstract][Full Text] [Related]
14. Low iodine diet for one week is sufficient for adequate preparation of high dose radioactive iodine ablation therapy of differentiated thyroid cancer patients in iodine-rich areas.
Lee M; Lee YK; Jeon TJ; Chang HS; Kim BW; Lee YS; Park CS; Ryu YH
Thyroid; 2014 Aug; 24(8):1289-96. PubMed ID: 24731156
[TBL] [Abstract][Full Text] [Related]
15. [In vivo test of thyroid radioactive iodide uptake, pertechnetate 99m uptake and thyroid scintigraphy].
Ochi Y; Kajita Y
Nihon Rinsho; 1997 Apr; 55 Suppl 2():317-20. PubMed ID: 9172537
[No Abstract] [Full Text] [Related]
16. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
17. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
18. Negative remnant
Lan W; Gege Z; Ningning L; Qiang W; Lin B; Qingjie M; Bin J
Ann Nucl Med; 2019 Feb; 33(2):112-118. PubMed ID: 30374858
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
[TBL] [Abstract][Full Text] [Related]
20. [Thyroid scintigraphy].
Secades I; Torres M; Arnáiz F; Castell M; La Banda JP
Rev Esp Med Nucl; 1999 Jun; 18(3):227-30. PubMed ID: 10475736
[No Abstract] [Full Text] [Related]
[Next] [New Search]
